CCAVENUE
Infibeam Avenues
Each stock's 10,000-path forecast, rendered as light.
Infibeam Avenues (CCAVENUE) Stock Analysis & Case Study
Is CCAVENUE a good buy? The data-driven verdict.
Infibeam Avenues (CCAVENUE) trades at ₹15,on the numbers it tread carefully, a Downstox Snapshot Score of 35/100.
On the numbers, Infibeam Avenues (CCAVENUE) tread carefully, a Downstox Snapshot Score of 35/100, weighing fairly valued at 18.5× earnings, ROE of 6.6%, a 13% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027–2031.
Last updated . Data snapshot for research, not investment advice.
CCAVENUE fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
Is CCAVENUE overvalued? CCAVENUE P/E vs its sector
CCAVENUE's P/E of 18.5× sits above the sector peer median of 15.9×, so on earnings it screens richer than peers.
CCAVENUE share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 2.0y of CCAVENUE history (-38%/yr drift, 40%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| CCAVENUE 2027 | ₹6 | ₹10 | ₹16 | -37% |
| CCAVENUE 2028 | ₹3 | ₹6 | ₹13 | -60% |
| CCAVENUE 2029 | ₹2 | ₹4 | ₹9 | -75% |
| CCAVENUE 2030 | ₹1 | ₹2 | ₹7 | -84% |
| CCAVENUE 2031 | ₹0 | ₹1 | ₹5 | -90% |
Median (P50) is the central estimate; the P10–P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability CCAVENUE goes up, or doubles?
The bull case for CCAVENUE
- A 18.5× P/E sits in the fair-value band, neither cheap nor stretched.
- Low price-to-book of 1.10×, the market is paying little over the company's net assets.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹9.
The bear case & risks
- Return on equity is a soft 6.6%, capital efficiency trails higher-quality peers.
- A low Piotroski F-Score of 3/9 flags weaker financial health this cycle, worth understanding why before committing.
- The probability model is cautious 12 months out, only a 13% chance of finishing above today's price.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹2.
CCAVENUE volatility & expected range, how bumpy is the ride?
Over the last 2.0 years CCAVENUE compounded at -38%/year with annualized volatility of 40%. That volatility implies a 1-year 80% range of ₹6–₹16, the honest backbone behind any single price target.
CCAVENUE price forecast, the full 60-month probability fan
CCAVENUE price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds CCAVENUE hits common targets within the simulated horizon?
Full multi-horizon detail on the CCAVENUE price target & forecast page.
CCAVENUE Piotroski F-Score: 3/9, how financially strong is it?
The Piotroski F-Score grades financial strength on nine profitability, leverage and efficiency checks. CCAVENUE scores 3/9,weak on the financial-strength checks.
CCAVENUE MTF margin & leverage, Upstox, Zerodha, Groww, Dhan
Margin Trading Facility lets you buy CCAVENUE with part of the capital. Lower margin % = higher leverage. Rates compared across brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 35.0% | 2.9× |
| ZerodhaCHEAPEST | 33.5% | 3.0× |
Compare every broker on the CCAVENUE MTF page.
CCAVENUE vs peers,sector comparison
About Infibeam Avenues: sector, index & market-cap context
Infibeam Avenues (CCAVENUE) is a small-cap NSE-listed company, and a constituent of the Nifty 500 index group, with a market capitalisation of ₹5,218 Cr. See more Nifty 500 stocks.
How the CCAVENUE Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Infibeam Avenues's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
CCAVENUE analysis, FAQs
Is Infibeam Avenues (CCAVENUE) a good buy?
On the numbers, Infibeam Avenues (CCAVENUE) tread carefully, a Downstox Snapshot Score of 35/100, weighing fairly valued at 18.5× earnings, ROE of 6.6%, a 13% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is CCAVENUE overvalued or undervalued?
CCAVENUE trades at 18.5× earnings versus a peer median of 15.9×, so it screens richer than its sector peers.
What is the CCAVENUE share price target for 2031?
CCAVENUE's probability-weighted 2031 median target is ₹1, with an 80% range of ₹0–₹5 (10,000-path Monte-Carlo).
What is the probability CCAVENUE doubles in 5 years?
The modelled probability of CCAVENUE reaching ₹30 (2×) within 5 years is 0%.
What is the bull case for CCAVENUE?
A 18.5× P/E sits in the fair-value band, neither cheap nor stretched. Low price-to-book of 1.10×, the market is paying little over the company's net assets.
What are the risks in CCAVENUE?
Return on equity is a soft 6.6%, capital efficiency trails higher-quality peers. A low Piotroski F-Score of 3/9 flags weaker financial health this cycle, worth understanding why before committing. The probability model is cautious 12 months out, only a 13% chance of finishing above today's price.